Literature DB >> 29722707

Multiple Sclerosis: An Update for Home Healthcare Clinicians.

Teri Capriotti1, Julia Noel, Simone Brissenden.   

Abstract

Multiple sclerosis (MS) is a chronic neurologic disease and the most common cause of nontraumatic disability in young adults in the United States. It strikes adults in the prime of life and can gradually diminish physical and mental function, affect relationships, employment, financial capacity, and independence. Neurologic symptoms fluctuate in a pattern of remissions and exacerbations for the majority of those with MS. A multidisciplinary treatment approach is essential. There are a wide number of medications that can be used. Treating the disease at an early stage within the first 5 years of clinical symptom onset is optimal. Home healthcare clinicians can use assessment tools to evaluate disease progression, teach the patient and family how to live with the disorder, and monitor the patient for medication side effects.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29722707     DOI: 10.1097/NHH.0000000000000666

Source DB:  PubMed          Journal:  Home Healthc Now        ISSN: 2374-4529


  2 in total

1.  Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain.

Authors:  Nitish Kumar; Nidhi Sharma; Rishabh Khera; Ria Gupta; Sidharth Mehan
Journal:  Metab Brain Dis       Date:  2021-02-26       Impact factor: 3.584

2.  Nrf2/HO-1 Signaling Stimulation through Acetyl-11-Keto-Beta-Boswellic Acid (AKBA) Provides Neuroprotection in Ethidium Bromide-Induced Experimental Model of Multiple Sclerosis.

Authors:  Shubham Upadhayay; Sidharth Mehan; Aradhana Prajapati; Pranshul Sethi; Manisha Suri; Ayat Zawawi; Majed N Almashjary; Shams Tabrez
Journal:  Genes (Basel)       Date:  2022-07-25       Impact factor: 4.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.